The Animal Antibacterial and Antibiotics Market is being driven by several key factors. Rising livestock production and ...

While you may think of healthcare as only covering human health, animal and pet health is also a growing sector. Click to ...

Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top ... relating to the approval status and labels of approved products may vary ...

The U.S. FDA Breakthrough Therapy designation is for the treatment of adults with non-cirrhotic metabolic ...

The U.S. FDA Breakthrough Therapy designation is for the treatment of adults with non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH) and moderate or advanced fibrosis, based on surv ...

Sanofi's wide lineup of branded drugs and vaccines and robust pipeline create strong cash flows and a wide economic moat. Growth of existing products and new product launches should help offset ...

Zoetis excels in innovation, creating new categories and consistently raising the standard of care, outperforming competitors ...

The board of trustees (the "Board") of NXG Cushing® Midstream Energy Fund (the "Fund") has approved the terms of the issuance of transferable rights ("Rights") to the holders of the Fund's common ...

The global veterinary biologics market is on a robust growth trajectory, with its valuation expected to reach USD 13,140.6 ...

In the future, around one third of the new products at Boehringer Ingelheim will come ... company active in both human and animal health. As one of the industry’s top investors in Research ...